Susan Hasty, Publisher
Table of Contents . . . March 22nd, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
Drug Development - PBD hybrids disrupt HIV RNA activity
Drug Development - PRO 542 shows promise as HIV salvage therapy
Drug Development - Benzothiepine and benzazepine derivatives show promise as oral CCR5 blockers
Drug Development - Small molecules with novel antiretroviral mechanisms developed
HIV/AIDS Dementia - Elevated ceramide production may underlie HIV neurotoxicity
HIV/AIDS Dementia - JNK/p38 inhibitors may protect against HIV-induced CNS disease
Biotechnology - DNA chip offers simultaneous detection of HIV, HBV and HCV in blood
Business Update - Distribution agreement dispute resolved for OraQuick Rapid HIV-1 Antibody Test
Drug Development - Novel nevirapine-like agents have improved activity against NNRTI-resistant HIV
Finance - NIH funds development of topical drug to protect from HIV, STDs
Finance - Three Maryland groups share part of federal AIDS grant
HIV/AIDS - Megestrol acetate NCD oral suspension NDA planned for third quarter 2004
HIV/AIDS - Mother of AIDS victim ordered to pay for lying to son's fiance
HIV/AIDS - Novel SIV strain isolated from Schmidt's guenon
HIV/AIDS Animal Models - Macaque SHIV model could aid research on env gene, pediatric infection
HIV/AIDS Cancer - HIV Tat linked to liver tumor development
HIV/AIDS Cancer - PAX2 plays key role in Kaposi sarcoma pathogenesis
HIV/AIDS Complications - VEGF levels rise in the serum of patients with HIV-linked neurological disease
HIV/AIDS Diagnosis - Indian finds AIDS diagnosis was wrong after killing family in despair
HIV/AIDS Drug Resistance - Different resistance mutations seen in blood and lungs of HIV patients
HIV/AIDS Drug Resistance - Peptide insertions in pol are rare cause of ART failure
HIV/AIDS Epidemiology - Frequency of AIDS prevention by restriction genes determined
HIV/AIDS Epidemiology - HIV rates high in both rural and urban Central African Republic
HIV/AIDS Opportunistic Infection - Cryptococcal meningitis prophylaxis not needed after immune recovery
HIV/AIDS Opportunistic Infection - Sulfadiazine pharmacokinetics similar when given two or four times a day
HIV/AIDS Pathogenesis - T-cell subsets harboring HIV in vivo have implications for HIV pathogenesis
HIV/AIDS Prevention - China, U.S. launch joint anti-AIDS program
HIV/AIDS Therapy - Effects of ART on sCD27 expression elucidated
HIV/AIDS Therapy - Lopinavir pharmacokinetics evaluated during Kaletra treatment
HIV/AIDS Therapy - Novel assay enables ddATP monitoring in ddI-treated patients
HIV/AIDS Therapy - Saquinavir exposure enhanced in HIV patients with diarrhea or wasting syndrome
HIV/AIDS Treatment - Dubuque mother and daughter to Africa as AIDS delegates
HIV/AIDS Trends - More than 11% Alabama AIDS cases among over-50s
HIV/AIDS Tuberculosis - PZA pharmacokinetics elucidated in HIV-TB patients
HIV/AIDS Vaccine - HIV vaccine antibodies bind more poorly than natural infection antibodies
HIV/AIDS Vaccine - SIV promoter exchange creates strain that protects against viral challenge
HIV/AIDS Women's Health - Oral lesions in HIV-positive women reduced in HAART therapy
Healthcare Access - Europe, Central Asia countries pledge "universal access" to HIV/AIDS treatment by 2005
Infectious Disease - Experts urge tools to protect women's health
Kaposi Sarcoma - KSHV K1 protein activates Akt cell survival pathway
Neuroscience - JAK2-STAT5 signaling needed for microglia activation by IL-3
Patents - Patent granted for AIDS treatment
Personnel - Development expert Robert Hecht to join AIDS vaccine nonprofit
Sexual Violence - Group says South African government's inaction hurts rape survivors
Spermicide - Condom retailer first to ban products containing nonoxynol-9
Stem-Cell Transplantation - Post-SCT eosinophilic pustular folliculitis described
Substance Abuse - Crystal methamphetamine use increases HIV risk
Virology - RNA molecules play important role as antiviral agents for cell treatment
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.